No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
UNCY Unicycive Therapeutics
- 0.8111
- +0.0115+1.44%
Close Dec 30 16:00 ET
- 0.8199
- +0.0088+1.08%
Post 20:01 ET
87.94MMarket Cap-1.76P/E (TTM)
0.8300High0.7773Low1.32MVolume0.8182Open0.7996Pre Close1.07MTurnover2.04%Turnover RatioLossP/E (Static)108.42MShares1.818052wk High3.16P/B52.35MFloat Cap0.202052wk Low--Dividend TTM64.54MShs Float8.7300Historical High--Div YieldTTM6.59%Amplitude0.2020Historical Low0.8080Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics
Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY)
Unicycive Therapeutics Price Target Maintained With a $3.00/Share by Benchmark
Unicycive Therapeutics to Participate in Two Upcoming Investor Conferences Including a Fireside Chat at the Piper Sandler 36th Annual Healthcare Conference
Maxim Group Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Announces Target Price $2
Express News | Unicycive Therapeutics Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
Heat List
US
Overall
Symbol
Price
% Chg
No Data